On the other hand, calcineurin inhibitors such as cyclosporine and tacrolimus are not associated with ADAMTS13 deficiency; these drugs considered to cause aHUS, which primarily induces vascular endothelial injury without decreasing ADAMTS13 activity, for which plasmapheresis is often ineffective. The gene discussed is ADAMTS13; the disease is atypical hemolytic-uremic syndrome.